スマートフォンのみで胎児心拍を計測可能なDopFoneアプリ(DopFone app can accurately track fetal heart rate using only a smartphone)

ad

2026-02-26 ワシントン大学

University of Washingtonの研究チームは、胎児心拍をスマートフォンで簡便に計測できるアプリ「DopFone」を開発した。従来は専用医療機器が必要だった胎児心拍モニタリングを、低コストかつ携帯可能な形で実現。スマホの音響機能と解析アルゴリズムを組み合わせ、ドップラー信号から胎児心拍数を抽出する。臨床評価では標準機器と高い一致率を示し、特に医療資源の限られた地域での妊産婦ケア向上が期待される。遠隔医療や早期リスク検知への応用も視野に入る成果である。

スマートフォンのみで胎児心拍を計測可能なDopFoneアプリ(DopFone app can accurately track fetal heart rate using only a smartphone)
DopFone uses an off-the-shelf smartphone’s existing speaker and microphone to accurately estimate fetal heart rate.
Photo: Garg et al./Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies

<関連情報>

DopFone: 市販スマートフォンを用いたドップラー法による胎児心拍数推定 DopFone: Doppler-Based Fetal Heart Rate Estimation Using Commodity Smartphones

Poojita Garg, Mingzhuo Ma, Hayley Jane MacKinnon, Michael Richley, Vikram Iyer, Shwetak Patel, Alexander T. Adams
Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies  Published: 02 December 2025
DOI:https://doi.org/10.1145/3770671

Abstract

Fetal heart rate (FHR) monitoring is critical for prenatal care, yet current methods rely on expensive, specialized equipment and trained personnel, limiting accessibility in low-resource and at-home settings. We present DopFone, a novel approach leveraging the built-in speaker and microphone of commodity smartphones to non-invasively estimate FHR via Doppler-based audio sensing. Our system emits an 18 kHz low-pitched ultrasound from the smartphone speaker and analyzes reflected signals recorded by the microphone to detect abdominal surface vibrations caused by fetal cardiac activity. Combining Doppler sensing with an AdaBoost regression model (validated via Leave-One-Out Cross-Validation on 23 pregnant participants), DopFone achieved a mean absolute error of 2.1±1.3 BPM compared to a reference-standard medical Doppler device. The 95% limits of agreement (±4.90 BPM) fall well within the clinically acceptable threshold of ±8 BPM. The system demonstrated robustness across gestational ages (19-39 weeks), maternal BMI (23-67 kg/m2), and variations in phone positioning. Our results establish that smartphones can deliver clinically reliable FHR estimation without external hardware, gel, or probes, bridging the gap between clinical monitoring and accessible at-home assessment.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました